{
  "docId": "019de070-c3f1-763f-aec8-8e853cc1bc89",
  "docSlug": "f47b98abe226393f6e944eb87df3d4ec",
  "documentTitle": "AbCellera | Results Presentation Deck | 23 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.5458937,
  "pageNumber": 10,
  "pageCount": 23,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": "Includes product imagery of the medication vial and packaging.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-c3f1-763f-aec8-8e853cc1bc89/10",
  "deckHref": "/decks/019de070-c3f1-763f-aec8-8e853cc1bc89",
  "deckJsonHref": "/decks/019de070-c3f1-763f-aec8-8e853cc1bc89.json",
  "deckAnchorHref": "/decks/019de070-c3f1-763f-aec8-8e853cc1bc89#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.3,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "image",
      "text": "Bamlanivimab vial and box",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77b92a71-2630-499f-b386-d02980c806a8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.45,
        "x": 0.5,
        "y": 0.55
      },
      "kind": "list",
      "text": "Reduce hospitalizations by 70% to 80% in patients recently diagnosed with mild to moderate COVID-19",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "26b9e549-92d1-4aca-8255-36c3e7a8b121",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.5,
        "y": 0.81
      },
      "kind": "list",
      "text": "Prevent COVID-19-related deaths",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5e9f9be4-872f-47ea-a806-9e6f8fcc2f4c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.45,
        "x": 0.5,
        "y": 0.68
      },
      "kind": "list",
      "text": "Prevent COVID-19 in nursing homes, reducing the risk of contracting COVID-19 by up to 80%",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "67293271-216e-406e-b04e-2ad4cffc5b17",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.7,
        "x": 0.05,
        "y": 0.23
      },
      "kind": "paragraph",
      "text": "Bamlanivimab has been evaluated both alone and together with other antibodies in 5,000+ patients across multiple clinical trials. Bamlanivimab alone has been shown to:",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ac2d41f5-ed95-47c4-bbe9-b5bf111fdfc6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.05,
        "y": 0.04
      },
      "kind": "title",
      "text": "2020 BUSINESS UPDATE. COVID-19 PROGRAM",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e36be26-2a56-4405-8934-4369604ec392",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.8,
        "x": 0.05,
        "y": 0.13
      },
      "kind": "title",
      "text": "~400K PATIENTS TREATED WITH BAMLANIVIMAB",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cd8dbac5-78ca-4159-b494-0cbd5e16db14",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "035ea2b7-1573-46af-bba0-afbd2e86d3ec",
      "evidence": "The slide contains a list of bullet points highlighting the benefits of Bamlanivimab.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 10,
      "from": 9,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "282f258a-6e2e-44b5-a8f4-77f2fc333813",
      "evidence": "The document presents the number of patients treated with bamlanivimab, highlighting the impact of AbCellera's technology.",
      "position": 0,
      "objective": "What are the consequences of not addressing COVID-19?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}